Vodudeutentan

Star0

DB17410ExperimentalSmall molecule

Vodudeutentan: Overview.

Formula / weight: C₃₄H₅₁N₅O₇ · 643.822 g/mol (avg)
Also known as: BQ-788 free acid, di(methyl-d)- · D-norleucine, n-((cis-2,6-di(methyl-d)-1-piperidinyl)carbonyl)-4-methyl-l-leucyl-1-(methoxycarbonyl)-d-tryptophyl-

Resolves to

Compound

UNII2YCH69X4OXCAS2364365-83-1

Structure

InChIKeyLPAHKJMGDSJDRG-ZEYDBOQPSA-NSMILES[2H]C[C@H]1CCC[C@@H](C[2H])N1C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@H](CC1=CN(C(=O)OC)C2=C1C=CC=C2)C(=O)N[C@H](CCCC)C(O)=O

Targets

P24530EDNRB

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Vodudeutentan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account